Søren Tulstrup, President and CEO, Hansa Biopharma said, "This phase 2 study of imlifidase in GBS is an important next step in understanding the rol...
Dermatology industry veteran Thibaud Portal, PhD appointed as CEO Granular Therapeutics, (Granular) a private biotech company specialising in p...
Patients with inflammatory diseases being treated with therapeutic monoclonal antibodies (mAbs) such as Infliximab may experience a significant increase in...
"There are many reasons parents elect to enroll children in clinical trials including access to vaccines that are not yet available to the general public, ...
How do you foresee digitalisation trends in APAC pharmaceutical supply chain improvising visibility, agility, and business resilience? Unpredict...
© 2025 Biopharma Boardroom. All Rights Reserved.
